← Leaderboards
Nicholas Pannunzio
University Of California-Irvine
$2,771,033
Attributed
$2,771,033
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $910.7K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,771,033 · 2
By mechanism
R37$2,085,711 · 1
R01$685,322 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California-Irvine
Same institution · by research overlap
- Veena A Satyanarayana$464,370
- Young Jik Kwon$358,950
Others in their field
Other Rising Stars on “Diagnosis”
- David Annett · Information Management Services, Inc.$35,571,865
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- John Alam · Eip Pharma, Inc.$10,411,018
Research focus
DiagnosisGeneticLinkMissionIgh@ Gene ClusterInnovationEarly DiagnosisActivation-Induced Cytidine DeaminaseGenome-WideHeavy-Chain ImmunoglobulinsAffectHuman DiseaseB-LymphocytesB Lymphoid MalignancyEpigenetic ProcessMapsDna Double Strand BreakDna RepairFosteringMolecularCellsGenomic InstabilityChromosomal TranslocationMortality
Grant awards (12)
Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations$406,847
R37 · FY2025 · CA · contact PI
Aberrant V(D)J recombination in B cells initiates lymphoid malignancy$342,661
R01 · FY2025 · CA · contact PI
Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations$417,842
R37 · FY2024 · CA · contact PI
Aberrant V(D)J recombination in B cells initiates lymphoid malignancy$342,661
R01 · FY2024 · CA · contact PI
Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations$76,185
R37 · FY2024 · CA · contact PI
Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations$74,013
R37 · FY2024 · CA · contact PI
Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations$416,589
R37 · FY2023 · CA · contact PI
Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations$77,439
R37 · FY2023 · CA · contact PI
Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations$76,351
R37 · FY2023 · CA · contact PI
Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations$421,097
R37 · FY2022 · CA · contact PI
Rapid detection of CRLF2 rearrangements in Hispanic Ph-like ALL patients to access diagnosis and relapse$59,674
R37 · FY2022 · CA · contact PI
Effect of dietary, pharmacological, and genetic topoisomerase ablation on Ph-like ALL risk in Hispanics$59,674
R37 · FY2022 · CA · contact PI